MedAssets Announces Strategic Partnership to Deliver

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
MedAssets Announces Strategic Partnership to Deliver Best-Practice Clinical Value Analysis Programs

ATLANTA, Dec. 1, 2014 (GLOBE NEWSWIRE) -- MedAssets (Nasdaq: MDAS ) today announced a strategic partnership with Procured Health to deliver a holistic approach to implementing best-practice clinical value analysis programs. Under terms of the agreement, MedAssets will augment its industry-leading clinical value analysis consulting and services with Procured Health's proprietary data intelligence and collaboration technology platform. The SaaS-based analytical tool and complementary purpose-built workflow solution provide hospital administrators and physicians unparalleled transparency into medical supply options and comparative safety and outcomes data. With improved market information and process oversight, hospitals are able to promote appropriate product utilization and optimize savings opportunities.

Now, through MedAssets, organizations can adopt a holistic approach to proven value analysis models, expert services, and an analytics and product research platform to help improve evaluation and purchasing of high-expense physician preference items (PPI) and other medical/surgical supplies.

"As the healthcare industry shifts to payment systems that reward doctors and hospitals for improving quality, it becomes more crucial than ever to analyze the resources used in delivering patient care in order to eliminate waste and variability," said John Bardis, chairman, president and chief executive officer, MedAssets. "MedAssets delivers best-in-class process improvement resources and services for value analysis, ranging from organizational readiness assessments to full program outsourcing. Procured Health's solutions will serve to further optimize our clients' clinical value analysis processes by delivering near real-time product performance research and automating the collaboration process among an organization's decision makers. We look forward to a positive working relationship to help our clients achieve higher levels of clinical performance as they pursue successful physician alignment strategies."

Procured Health's solutions include:

  • IntelligencePRO™: a SaaS-based clinician-oriented platform that provides in-depth, clinical and operational analysis on any medical product. The proprietary database leverages a specialized pool of biomedical engineers and clinicians to offer comparative safety and outcomes data in order to promote purchasing decisions that are based on comprehensive clinical evidence.
  • EvaluationPRO™: a SaaS-based project management system designed specifically for the hospital value analysis process. The solution digitizes product requests and automates strategic sourcing projects in order to drive efficiency, productivity and collaboration between clinicians and administrators. In addition, it provides essential reporting on operational and financial metrics to reduce care variation, improve contract compliance, and maximize system-wide savings opportunities.  

"Vanderbilt's Medical and Economics Outcome Committees (MEOC) are clinician-driven processes that utilize evidenced-based, clinically sound, financially responsible methodologies to evaluate new products and technologies in the effort to provide the highest quality care," said Teresa Dail, chief supply chain officer, Vanderbilt University Medical Center. "While using this type of approach has been foundational for the past seven years, the rigor required to access and then assess the literature has been a continuous challenge. Having the ability to provide a comprehensive, unbiased, easily accessible assessment of a new product or technology that includes peer reviewed literature has taken our process to a much more desirable state. As we address the economic challenges before us, it is even more of an imperative that we are able to ensure that the decisions being made are focused on driving total value."

"Our technology solutions are designed to help transform how medical products are chosen, negotiated for and utilized. Traditionally, care givers and administrators have had to rely upon product manufacturers for information," said Hani Elias, chief executive officer, Procured Health. "By taking a 21 st century, technology-oriented approach to the medical device marketplace, we aim to solve the underlying issues that lead to wasteful healthcare spending, which is an incredible burden to patients, physicians and hospitals. We look forward to combining our capabilities with MedAssets clinical value analysis solutions to help hospitals and physicians realize immediate financial and clinical benefits."

Collaboration to Offer Increased Alignment in Clinical Resource Management and Quality Improvement Efforts

Supplies and drugs represent 25 percent of a typical hospital's supply budget, of which about 40 percent is spent on physician preference items, such as orthopedic implants. Supplies represent hospitals' fastest growing expense category. MedAssets brings two decades of experience in delivering more than 400 successful, clinician engagement programs designed to link financial and clinical data. Clinical Resource Management Solutions , Cost Analytics and Operational Analytics tools are delivered through a proven, data-driven methodology to uncover deficiencies and utilization variation in order to align cost per case. The result is sustainable cost reductions while aligning clinical delivery to outcomes and quality.

About Procured Health

Procured Health is a leading developer of web-based solutions to improve evaluation and purchasing of medical products. Its innovative services include a comparative device-information platform and a product-evaluation workflow solution that leverage data science, market intelligence, and clinical insights to enable members to understand industry dynamics, identify competition, discover opportunities, and accelerate decision-making and implementation. Procured Health is based in Chicago, Ill. For more information, please visit www.procuredhealth.com .           

About MedAssets

MedAssets (Nasdaq: MDAS ) is a healthcare performance improvement company focused on helping providers realize financial and operational gains so that they can sustainably serve the needs of their community. More than 4,400 hospitals and 122,000 non-acute healthcare providers currently use the company's evidence-based solutions, best practice processes and analytics to help reduce the total cost of care , enhance operational efficiency , align clinical delivery , and improve revenue performance across the care continuum. For more information, please visit www.medassets.com .

MDAS/F

Media Contact: Robin Wrinn 678.624.7420 Investor Contact: Robert Borchert 678.248.8194

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Happiest Minds Extends Absa Banking Platform Reach

Updated Category News Views 34

Mauritius just handed Happiest Minds a useful, if modest, banking-tech scorecard. On November 19, 2026, the company said its cloud-native Arttha platform had been deployed to support selected capabilities within Spark by Absa, a digital banking and lifestyle app from Absa Bank (Mauritius). This is not the sort of announcement that lets anybody pencil in a giant revenue...

Continue Reading
California Budget Warning Puts Reserves Back in Focus

Updated Category News Views 118

California’s rainy-day umbrella is getting another hard look, and it should. State Controller Malia M. Cohen is pointing to the Legislative Analyst’s Office fiscal outlook as a reminder that budget discipline and stronger reserves are not ornamental good-government phrases. They are the difference between absorbing a revenue wobble and reaching for ugly fixes after...

Continue Reading
MSD's AI Drug Bet Has Promise, but Plenty to Prove

Updated Category News Views 0

A promising molecule remains a very expensive guess until biology agrees. That is the sober lens for MSD's newly announced research collaboration with Isomorphic Labs: potentially meaningful science, certainly interesting strategic positioning, and absolutely no reason yet to start penciling in product sales. One Oncology Target, Not a Finished Drug On November 19, 2026,...

Continue Reading
FAMID's Six-Month IVDR Win Opens Europe's Market Door

Updated Category News Views 34

A six-month regulatory sprint is the sort of result that makes a crowded diagnostics field pause and squint. DNV has issued an IVDR certificate to FAMID Biomedical Technology for its E7 Oncoprotein Rapid Test Kit, a Class C in vitro diagnostic intended to aid diagnosis of cervical epithelial cell lesions through detection of HPV E7 oncoprotein in cervical cell samples....

Continue Reading
Youdao Sets December AGM With No Vote on the Table

Updated Category News Views 74

A shareholder meeting without a vote is more temperature check than showdown, and that is exactly what Youdao has scheduled for December 17, 2026. The company will gather shareholders from 3:00 p.m. to 5:00 p.m. Beijing time at its Beijing office, but it has made one point painfully clear: no proposal will be submitted for shareholder approval. For holders of NYSE: DAO,...

Continue Reading
JOYY Q3 Growth Shows More Than Livestreaming Muscle

Updated Category News Views 39

Revenue finally has more than one pair of legs at JOYY, and that matters a whole lot more than a flashy quarterly headline. The company reported third-quarter 2026 revenue of US$624.6 million, up 15.6% from a year earlier and 5.7% from the prior quarter. Those are not microscopic moves, and the composition is the part that deserves the hard stare. JOYY is still rooted in...

Continue Reading
A Hybrid Book Bets on Muscles, Myth, and Machines

Updated Category News Views 66

Few publishing pitches ask readers to carry a barbell into Tartarus, but A R Quigley is plainly not chasing the middle of the bookstore. Doctrina Machina Learning Machine, released by Palmetto Publishing in November 2026, welds together a strength-training guide and an underground military science-fiction war story. That is an odd little contraption, no use pretending...

Continue Reading
Innoviz's 1-for-20 Split Is a Listing Lifeline Test

Updated Category News Views 93

A twenty-share pile of INVZ is about to become one share, and nobody should confuse that paperwork with a turnaround. Innoviz plans to enact a 1-for-20 reverse split at 11:59 p.m. Eastern on Friday, December 4, with split-adjusted trading expected when Nasdaq opens on December 7. This is a blunt instrument aimed at one immediate problem: getting the quoted share price...

Continue Reading
SAGA's Radar Assays Tighten the Trapper North Case

Updated Category News Views 188

Rock that keeps showing up where the model says it should is the sort of boring news a junior miner desperately needs. SAGA Metals has put out fresh assay results from Radar’s Trapper North area, and the useful part is not merely a loud grade in one hole. It is the apparent persistence of thick titanium-vanadium-iron oxide mineralization across tighter-spaced drilling....

Continue Reading
Scenthound’s Franchise Award Spotlights a Real Test

Updated Category News Views 169

A clean dog may not sound like a growth story, yet Scenthound has turned that neglected chore into a surprisingly serious franchise proposition. The company has won the International Franchise Association’s Emerging Franchisor Award after building its dog-hygiene concept from a 2015 founding into a network with more than 180 open locations. That is a respectable piece...

Continue Reading

Top 5 Most Recently Viewed Articles

Galderma Showcases Innovations in Dermatology at EADV 2024

Updated Category News Views 262

Galderma's Role at EADV 2024 At the upcoming European Academy of Dermatology and Venereology (EADV) congress, Galderma is set to highlight its important advancements in dermatology. This congress serves as a vital platform where dermatology professionals come together to exchange knowledge, explore new insights, and delve into the latest developments within the field....

Continue Reading
Exploring Growth Factors in the Scoliosis Management Sector

Updated Category News Views 131

Growth Potential in the Scoliosis Management Market Recent analyses reveal an exciting trajectory for the global scoliosis management market, projected to reach a remarkable $4.39 billion by 2034. This growth is fueled by an expected compound annual growth rate (CAGR) of 3.7% throughout the period. A significant push behind this bright future comes from the increasing...

Continue Reading
Celebrating 5 Years of Luxury Home Building with JASPER

Updated Category News Views 375

JASPER Marks Five Years of Distinctive Home Building JASPER, Nashville's foremost luxury builder, takes pride in celebrating five remarkable years of creating custom homes and inspiring renovations with a focus on precision, honesty, and a customer-centered approach. Establishing a Reputable Foundation Since its inception, JASPER has become synonymous with quality in...

Continue Reading
La Rosa Holdings Strengthens Agent Platform for Growth

Updated Category News Views 92

La Rosa Holdings Enhances Agent Platform La Rosa Holdings Corp. (NASDAQ:LRHC) has recently unveiled an upgraded version of its proprietary platform, My Agent Account, which includes a new property management module aimed at increasing operational efficiency for its agents. The My Agent Account platform has been gaining traction, evidenced by a remarkable 19%...

Continue Reading
Alkaline Water Company Partners for Expansion in New Markets

Updated Category News Views 153

Alkaline Water Company Enhances Global Presence The Alkaline Water Company, Inc. (OTC: WTER), known for its premium hydration solutions, has recently made significant strides in expanding its international footprint. In a notable move, the company has entered into a strategic international sales and distribution agreement with Global Brand and Export Development, LLC....

Continue Reading